Modular Medical, Inc. (MODD) Financial Statements (2026 and earlier)

Company Profile

Business Address 10740 THORNMINT ROAD
SAN DIEGO, CA 92127
State of Incorp. NV
Fiscal Year End March 31
Industry (SIC) 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) (USD)

3/31/2026
Q4
12/31/2025
Q3
9/30/2025
Q2
6/30/2025
Q1
3/31/2025
Q4
12/31/2024
Q3
9/30/2024
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments2,937,0005,316,0007,522,00013,095,0006,986,000250,000
Cash and cash equivalent2,937,0005,316,0007,522,00013,095,0006,986,000250,000
Receivables13,00025,00077,00070,000  
Prepaid expense516,000606,000693,000352,000  
Other undisclosed current assets     345,0003,926,000
Total current assets:3,466,0005,947,0008,292,00013,517,0007,331,0004,176,000
Noncurrent Assets
Operating lease, right-of-use asset466,000568,000667,000765,000860,000954,000
Property, plant, and equipment, after accumulated depreciation, depletion, and amortization6,327,0006,459,0005,212,0004,453,0003,958,0003,641,000
Other noncurrent assets      
Total noncurrent assets:6,793,0007,027,0005,879,0005,218,0004,818,0004,595,000
TOTAL ASSETS:10,259,00012,974,00014,171,00018,735,00012,149,0008,771,000
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities1,715,0003,594,0001,613,000842,000973,000846,000
Accounts payable1,008,0002,879,0001,067,000338,000522,000501,000
Accrued liabilities707,000715,000546,000504,000451,000345,000
Other undisclosed current liabilities464,000450,000437,000423,000410,000398,000
Total current liabilities:2,179,0004,044,0002,050,0001,265,0001,383,0001,244,000
Noncurrent Liabilities
Liabilities, other than long-term debt 40,000161,000278,000393,000504,000611,000
Operating lease, liability 40,000161,000278,000393,000504,000611,000
Other undisclosed noncurrent liabilities 2,159,000     
Total noncurrent liabilities: 2,199,000161,000278,000393,000504,000611,000
Total liabilities:4,378,0004,205,0002,328,0001,658,0001,887,0001,855,000
Equity
Equity, attributable to parent, including:5,881,0008,769,00011,843,00017,077,00010,262,0006,916,000
Common stock78,00061,00055,00054,00041,00034,000
Additional paid in capital112,402,000107,515,000103,243,000101,776,00090,047,00081,904,000
Accumulated deficit(106,605,000)(99,245,000)(91,455,000)(84,753,000)(79,826,000)(75,022,000)
Other undisclosed equity, attributable to parent 6,000438,000    
Total equity:5,881,0008,769,00011,843,00017,077,00010,262,0006,916,000
TOTAL LIABILITIES AND EQUITY:10,259,00012,974,00014,171,00018,735,00012,149,0008,771,000

Income Statement (P&L) (USD)

3/31/2026
Q4
12/31/2025
Q3
9/30/2025
Q2
6/30/2025
Q1
3/31/2025
Q4
12/31/2024
Q3
9/30/2024
Q2
Revenues
(Other Income)
13,00041,000 203,00050,00042,000
Gross profit:13,00041,000 203,00050,00042,000
Operating expenses(7,244,000)(7,829,000)(6,804,000)(5,838,000)(4,854,000)(4,996,000)
Other undisclosed operating income (loss)(13,000)(41,000) (203,000)(50,000)(42,000)
Operating loss:(7,244,000)(7,829,000)(6,804,000)(5,838,000)(4,854,000)(4,996,000)
Nonoperating income   102,000   
Loss from continuing operations before equity method investments, income taxes:(7,244,000)(7,829,000)(6,702,000)(5,838,000)(4,854,000)(4,996,000)
Other undisclosed income (loss) from continuing operations before income taxes(116,000)41,000 203,00050,00042,000
Loss from continuing operations before income taxes:(7,360,000)(7,788,000)(6,702,000)(5,635,000)(4,804,000)(4,954,000)
Income tax expense  (2,000)   (2,000)
Net loss available to common stockholders, diluted:(7,360,000)(7,790,000)(6,702,000)(5,635,000)(4,804,000)(4,956,000)

Comprehensive Income (USD)

3/31/2026
Q4
12/31/2025
Q3
9/30/2025
Q2
6/30/2025
Q1
3/31/2025
Q4
12/31/2024
Q3
9/30/2024
Q2
Net loss:(7,360,000)(7,790,000)(6,702,000)(5,635,000)(4,804,000)(4,956,000)
Comprehensive loss, net of tax, attributable to parent:(7,360,000)(7,790,000)(6,702,000)(5,635,000)(4,804,000)(4,956,000)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: